Showing results (611-620 of 941) with videos related to

Sort By:
Pageof 95
Diabetes & Vascular Disease Research|March 10, 2016
Examining the relationship between HbA1c and diabetes risk models in a European population indicates a lower threshold to identify 'high risk' is requiredBenjamin J Gray, Richard M Bracken, Daniel Turner, et al.
Diabetes & Vascular Disease Research|June 24, 2016
Diabetes mellitus is associated with adverse structural and functional cardiac remodelling in chronic heart failure with reduced ejection fractionAndrew Mn Walker, Peysh A Patel, Adil Rajwani, et al.
Diabetes & Vascular Disease Research|May 19, 2016
Considerably decreased risk of cardiovascular disease with combined reductions in HbA1c, blood pressure and blood lipids in type 2 diabetes: Report from the Swedish National Diabetes RegisterKatarina Eeg-Olofsson, Björn Zethelius, Soffia Gudbjörnsdottir, et al.
Diabetes & Vascular Disease Research|May 19, 2016
Linagliptin and pioglitazone combination therapy versus monotherapy with linagliptin or pioglitazone: A randomised, double-blind, parallel-group, multinational clinical trialMichael Albrecht Nauck, Maximiliano di Domenico, Sanjay Patel, et al.
Diabetes & Vascular Disease Research|December 6, 2017
An analysis of barriers to entry of cardiac rehabilitation in patients with diabetes: Using data from the National Audit of Cardiac RehabilitationAlexander S Harrison, Patrick Doherty, Anne Phillips
Diabetes & Vascular Disease Research|December 1, 2017
Combined serum free light chain levels are associated with carotid atherosclerosis in type 2 diabetes mellitusFelix Aberer, Norbert Joachim Tripolt, Hubert Scharnagl, et al.
Diabetes & Vascular Disease Research|October 21, 2017
High overall cardiovascular risk and mortality in patients with atrial fibrillation and diabetes: A nationwide reportStelios Karayiannides, Pia Lundman, Leif Friberg, et al.
Diabetes & Vascular Disease Research|November 2, 2017
Serum cystatin C is associated with subclinical atherosclerosis in patients with type 2 diabetes: A retrospective studyYu Kyung Chung, Young Ju Lee, Kye Whon Kim, et al.
Diabetes & Vascular Disease Research|September 5, 2017
The tumour suppressor CDKN2A/p16INK4a regulates adipogenesis and bone marrow-dependent development of perivascular adipose tissueKristiaan Wouters, Yann Deleye, Sarah A Hannou, et al.
Diabetes & Vascular Disease Research|October 5, 2017
Dapagliflozin attenuates human vascular endothelial cell activation and induces vasorelaxation: A potential mechanism for inhibition of atherogenesisTracey Gaspari, Iressa Spizzo, HongBin Liu, et al.
Pageof 95